HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.

Abstract
Ciclopirox is a broad-spectrum antifungal, antibacterial, and anti-inflammatory agent. This open-label study investigated the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans (C. albicans). Forty-four male and female subjects aged 6 to 29 months were included in the study. Study medication was applied topically to the affected diaper area twice daily for 1 week. Subjects were clinically evaluated at baseline and days 3, 7, and 14 (7 days post-treatment). Safety and efficacy variables included adverse events, mycological culture studies, KOH tests, Severity Scores, and Global Evaluation of Clinical Response. All adverse events were mild to moderate and considered not related to the study medication. Treatment provided statistically significant improvement (P < .05) for both the rate of mycological cure and reduction of Severity Score at each time point compared with baseline. Ciclopirox was safe and effective in the treatment of diaper dermatitis due to C. albicans.
AuthorsElizabeth Gallup, Todd Plott,
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) 2005 Jan-Feb Vol. 4 Issue 1 Pg. 29-34 ISSN: 1545-9616 [Print] United States
PMID15696982 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)
Chemical References
  • Antifungal Agents
  • Pyridones
  • Suspensions
  • ciclopirox
Topics
  • Administration, Topical
  • Antifungal Agents (administration & dosage, adverse effects, therapeutic use)
  • Candidiasis, Cutaneous (drug therapy, microbiology, pathology)
  • Child, Preschool
  • Dermatitis (drug therapy, microbiology, pathology)
  • Diaper Rash (drug therapy, microbiology, pathology)
  • Female
  • Humans
  • Infant
  • Male
  • Pyridones (administration & dosage, adverse effects, therapeutic use)
  • Suspensions
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: